/ Glenmark Pharma Plunges Over 2% BSE Healthcare In Red ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Monday, 24 April 2017

Stocks of the pharma player, Glenmark Pharmaceuticals, are trading in a bearish mood, wherein the scrip is trading in negative territory on BSE, down by over 2% at Rs 882 per share, at morning hours.

On April 19, the pharma player received tentative approval from the U.S. FDA for Dabigatran Etexilate Capsules, 75 mg, 110 mg and 150 mg, the generic version of Pradaxa Capsules, 75 mg, 110 mg and 150 mg of Boehringer Ingelheim Pharmaceuticals, Inc.

The healthcare index, BSE Healthcare is diving downwards, trading in negative territory, down over 111 points or 0.73% at 15077 levels at 11:20 IST.

Glenmark Pharma is majorly contributing to the index's downfall. The stock has outperformed BSE Healthcare index, and underperformed BSE Sensex on a yearly basis. 

At 11:20 IST there are 1042 advances, 573 declines and 356 unchanged stocks, indicative of a positive vibe in the bourses.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 
Give a Missed Call for Free Trial - 09699997717